Cargando…

Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are

Cells and extracellular matrix (ECM) components represent the multifaceted and dynamic environment that distinguishes each organ. Cancer is characterized by the dysregulation of the composition and structure of the tissues, giving rise to the tumor milieu. In this review, we focus on the microenviro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saggioro, Mattia, D'Angelo, Edoardo, Bisogno, Gianni, Agostini, Marco, Pozzobon, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063801/ https://www.ncbi.nlm.nih.gov/pubmed/32195166 http://dx.doi.org/10.3389/fonc.2020.00076

Ejemplares similares

Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment
por: D'Angelo, Edoardo, et al.
Publicado: (2020)

Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
por: Cova, Ilaria, et al.
Publicado: (2018)

Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Where We Are and Where We Need to Go
por: Liu, Xiaohao, et al.
Publicado: (2020)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

Cancer treatment data available in European cancer registries: Where are we and where are we going?
por: Giusti, Francesco, et al.
Publicado: (2023)

Managing sarcoma: where have we come from and where are we going?
por: Bleloch, Jenna S., et al.
Publicado: (2017)

Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?
por: Mannavola, Francesco, et al.
Publicado: (2019)

Metabolic Imaging in Prostate Cancer: Where We Are
por: Testa, Claudia, et al.
Publicado: (2016)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
por: Rizzo, Alessandro, et al.
Publicado: (2021)

Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study
por: D’Agostino, Stefania, et al.
Publicado: (2021)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
por: Hu, Li-Feng, et al.
Publicado: (2021)

Where are we going with sentinel nodes mapping in ovarian cancer?
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2022)

Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment
por: Koo, Jane, et al.
Publicado: (2020)

The future of high-grade glioma: Where we are and where are we going
por: Rhun, Emilie Le, et al.
Publicado: (2015)

Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams
por: Pan, Darren, et al.
Publicado: (2022)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

Editorial: Current innovations in GI-oncology: Where do we stand?
por: Rumpold, Holger, et al.
Publicado: (2022)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

Long non-coding RNA and extracellular matrix: the hidden players in cancer-stroma cross-talk
por: D'Angelo, Edoardo, et al.
Publicado: (2018)

Tumor microenvironment complexity and therapeutic implications at a glance
por: Baghban, Roghayyeh, et al.
Publicado: (2020)

Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy
por: Cavaliere, Elena, et al.
Publicado: (2014)

Promoting Physical Activity in Pediatric Oncology. Where Do We Go from Here?
por: Viña, Carolina Chamorro, et al.
Publicado: (2013)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

Heart failure and telemedicine: where are we and where are we going? Opportunities and critical issues
por: Calò, Leonardo, et al.
Publicado: (2023)

Editorial: Unravelling the sarcoma microenvironment: Impact of the genomic landscape on molecular signaling, immunosuppression, and treatment resistance
por: Dickerson, Erin B., et al.
Publicado: (2023)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

The genetic patterns of bladder cancer. Where do we stand now?
por: Salagierski, Maciej
Publicado: (2013)

Editorial: Preoperative Frailty Risk Assessment Prior to Esophagectomy, Where Are We?
por: Fay, K. A., et al.
Publicado: (2023)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
por: Cellini, Alessandro, et al.
Publicado: (2023)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?
por: Ricco, Gianluca, et al.
Publicado: (2021)

The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?
por: Dhawan, Annika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uud7f1cul9cvkv6f846b8olpo3